Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00359281Phase 2Completed
A Phase 2 trial of lomitapide in hypercholesterolemia, sponsored by Aegerion Pharmaceuticals. Started Mar 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00359281.